<ѻý>Retinal Tumor Risk Incidentally Detected at 29 Weeks' Gestationѻý> Finding poses clinical and ethical dilemma for parents and clinicians Jan 08, 2024
<ѻý>FDA Leaders' Vaccination Warning; Michael Bolton's Brain Tumor; JN.1 Now Dominantѻý> Health news and commentary from around the Web gathered by ѻý staff Jan 08, 2024
<ѻý>Collaboration Between Local Oncologists and Academia Is Crucialѻý> Greater partnerships can optimize cancer care outcomes Jan 06, 2024
<ѻý>Language Minimizing Adverse Events; HPV and Thyroid Cancer; Ultrasound Brasѻý> News, features, and commentary about cancer-related issues Jan 05, 2024
<ѻý>MeCo Score May Predict Metastatic Progression in Breast Cancerѻý> Seeing whether it can predict response to antifibrotic therapies is next step Jan 05, 2024 video
<ѻý>U.S. Rep's Death Medical Negligence? FDA Investigates GLPs; Fingerprint Mammogramsѻý> Health news and commentary from around the Web gathered by ѻý staff Jan 05, 2024
<ѻý>Study Assuages Fears of Pancreatic Cancer Risk With GLP-1 Receptor Agonistsѻý> Researchers looked at 7-year patient data Jan 04, 2024
<ѻý>Axi-Cel Shows Durable Responses, Prolongs Overall Survival in Older LBCL Patientsѻý> Our panel discusses findings from the ZUMA-12 study and the ZUMA-7 study Jan 04, 2024 video
<ѻý>Daratumumab Added to Standard Therapy Improves PFS in Multiple Myelomaѻý> Subcutaneous administration of the anti-CD38 antibody also made for easier dosing Jan 04, 2024
<ѻý>Liso-Cel a Potential New CAR-T Option for High-Risk R/R Follicular Lymphomaѻý> Study results show impressive efficacy, favorable safety profile in the second line Jan 04, 2024 video
<ѻý>Futile Immunotherapy for Cancer Grows More Commonѻý> Occurs most often at non-academic and low-volume centers Jan 04, 2024
<ѻý>Combination Shows Promise in Metastatic ESR1-Mutant Breast Cancerѻý> Durable responses with lasofoxifene plus abemaciclib in post-CDK4/6 inhibitor setting Jan 03, 2024
<ѻý>Paramagnetic Seeds: An Effective Option for Breast Lesion Localizationѻý> Study finds seeds-SPIO combo compares favorably with guidewire-SPIO for breast-conserving surgery Jan 02, 2024
<ѻý>Lessons From the Chemotherapy Shortages: Invest in Genericsѻý> We need more sustainable solutions to ensure treatment access Dec 31, 2023
<ѻý>Cancer Patients Face Frightening Delays in Treatment Approvalsѻý> "For them to take weeks -- up to months -- to provide an authorization is ridiculous" Dec 30, 2023
<ѻý>Gene Therapy for Hemophilia Becomes a Realityѻý> Uptake of new options for hemophilia A and B has been a bit slow Dec 29, 2023
<ѻý>Financial Toxicity Among Single Mothers With Metastatic Breast Cancerѻý> Diagnosis coupled with financial burden makes for a difficult situation, but help is out there Dec 29, 2023 video
<ѻý>Another CAR-T Warning; 'Sweet' Cancer Test; 'Molecular Jackhammer' Blows Up Cancerѻý> News, features, and commentary about cancer-related issues Dec 28, 2023
<ѻý>Testosterone for Hypogonadism Cleared So Far of Prostate Cancer Riskѻý> No excess high-grade or overall prostate cancer risk in TRAVERSE with 33 months of follow-up Dec 27, 2023
<ѻý>Chemo-Free Quadruplet Promising as Initial Treatment in DLBCLѻý> Approach could allow for a response-adapted reduction of CHOP Dec 27, 2023 video
<ѻý>Mind of the 'Maestro': Inside the Head of Leonard Bernsteinѻý> Psychiatrist and concert pianist Richard Kogan, MD, on the great composer's complex inner life Dec 27, 2023
<ѻý>Longer Letermovir Prophylaxis Reduced Risk of Cytomegalovirus Infection After HSCTѻý> Randomized study showed extending prophylaxis from 100 to 200 days was effective and safe Dec 27, 2023
<ѻý>Significant Left Nasal Obstruction Finally Diagnosed After 2 Yearsѻý> Nonspecific presentation impedes early diagnosis of rare indolent tumor in older man Dec 26, 2023
<ѻý>Tisa-Cel Yields Durable Responses in R/R Follicular Lymphomaѻý> Our panel of experts discuss 3-year findings from the phase II ELARA study Dec 26, 2023 video
<ѻý>SABCS 2023 Highlights Open the Door for More Key Data in 2024ѻý> Virginia Kaklamani, MD, discusses this year's sessions of interest and looks ahead to next year Dec 22, 2023 video
<ѻý>Mammo Responsibility Ups Screening; Opioids for Cancer Pain? Ignored Signs of CRCѻý> News, features, and commentary about cancer-related issues Dec 21, 2023
<ѻý>Can JAK Inhibition Help Overcome Lenalidomide Resistance in Myeloma?ѻý> Early-phase experience with ruxolitinib suggests potential role in relapsed/refractory disease Dec 21, 2023 video
<ѻý>Homelessness Tied to Worse Cancer Outcomes Among Veteransѻý> However, all-cause mortality rates in lung, colon cancer lower versus other healthcare settings Dec 21, 2023
<ѻý>Responses to Mosunetuzumab in Follicular Lymphoma Remain Durable at 3 Yearsѻý> Bispecific antibody also shows high response rates in frontline setting Dec 20, 2023 video
<ѻý>Positive Results for Odronextamab in Relapsed/Refractory DLBCLѻý> But experts aren't sure where it would fit in with currently approved bispecifics Dec 20, 2023 video
<ѻý>'Curable': A Case for Precision of Languageѻý> Patients need a clear description of their prognosis Dec 19, 2023
<ѻý>Psilocybin May Help Ease Depression in Cancer Patientsѻý> In small trial, half had early remission of depressive symptoms after psilocybin-assisted therapy Dec 18, 2023
<ѻý>National Database Study Finds Higher Risk for Barrett’s Esophagus in IBDѻý> But no greater chance of BE-tied malignancy for these patients Dec 16, 2023
<ѻý>The 'Before and After': An Eye Surgeon's Unexpected Findingѻý> There are a few possible diagnoses in patient with headaches, blurred vision, but one stands out Dec 16, 2023
<ѻý>FDA Approves New First-Line Standard of Care in Bladder Cancerѻý> Enfortumab vedotin plus pembrolizumab doubled survival as compared with chemotherapy Dec 15, 2023
<ѻý>JAK1 Inhibitor Shows 'Remarkable' Activity in T-Cell Lymphomaѻý> Phase II findings on golidocitinib will form the basis of an accelerated approval application Dec 15, 2023
<ѻý>Hematocrit Stabilized in Polycythemia Vera Treated With Novel Hepcidin Mimeticѻý> Rusfertide maintained hematocrit Dec 15, 2023
<ѻý>Atezolizumab Plus Carboplatin Boosts Survival in Metastatic TNBCѻý> But editorialists note that with recent advances, "it is hard to justify" use of combination Dec 15, 2023
<ѻý>FDA Approves Belzutifan for Advanced Renal Cell Carcinomaѻý> HIF-2 inhibitor indicated for patients who progress after immunotherapy and anti-VEGF Dec 15, 2023
<ѻý>Why Some Myeloma Patients Refuse Stem Cell Transplantѻý> Study shows the various factors behind refusal of autologous stem cell transplantation Dec 15, 2023 video